Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 26, 2026.

An 81-Nucleotide Deletion in SARS-CoV-2 ORF7a Identified from Sentinel Surveillance in Arizona (January to March 2020)

LaRinda A. Holland, Emily A. Kaelin, Rabia Maqsood and 7 more

Journal of Virology · 2020 · CC BY

doi:10.1101/2020.04.17.20069641

Abstract

On January 26 2020, the first Coronavirus Disease 2019 (COVID-19) case was reported in Arizona of an individual with travel history (3 rd case in the US) (1). Here, we report on early SARS-CoV-2 sentinel surveillance in Tempe, Arizona (USA). Genomic characterization identified an isolate encoding a 27 amino acid in-frame deletion in accessory protein ORF7a, the ortholog of SARS-CoV immune antagonist ORF7a/X4.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 26, 2026. Paragraph numbers are ours, so an answer can point at one.

On January 26 2020, the first Coronavirus Disease 2019 (COVID-19) case was reported in Arizona of an individual with travel history (3rd case in the US). Here, we report on early SARS-CoV-2 sentinel surveillance in Tempe, Arizona (USA). Genomic characterization identified an isolate encoding a 27 amino acid in-frame deletion in accessory protein ORF7a, the ortholog of SARS-CoV immune antagonist ORF7a/X4.

In anticipation of COVID-19 spreading in the state of Arizona, we initiated a surveillance effort for local emergence of SARS-CoV-2 starting January 24, 2020. We leveraged an ongoing influenza surveillance project at Arizona State University (ASU) Health Services in Tempe, Arizona. Individuals presenting with respiratory symptoms (ILI) were tested for influenza A and B virus (Alere BinaxNOW). Subsequently, we tested influenza-negative nasopharyngeal (NP) swabs for SARS-CoV-2. We extracted total nucleic acid using the bioMérieux eMAG automated platform and performed real-time RT-PCR (qRT-PCR) assays specific for SARS-CoV-2 N and E genes. Out of 382 NP swabs collected from January 24, 2020 to March 25, 2020, we detected SARS-CoV-2 in 5 swabs in the week of March 16 to 19 (Figure 1). This corresponds to prevalence of 1.31%. Given the estimated 1 – 14-day incubation period for COVID-19, it is possible that the spike in cases might be related to university spring-break holiday travel (March 8 – 15) as previously seen in other outbreaks.

To understand the evolutionary relationships and characterize the SARS-CoV-2 genomes, we performed next-generation sequencing (Illumina NextSeq, 2×76) directly on specimen RNA, thereby avoiding cell culture passage and potentially associated mutations. This generated an NGS dataset of 20.7 to 22.7 million paired-end reads per sample. We mapped quality-filtered reads to a reference SARS-CoV-2 genome (MN908947) using BBMap (version 39.64) to generate three full-length genomes: AZ-ASU2922 (376x coverage), AZ-ASU2923 (50x) and AZ-ASU2936 (879x) (Geneious prime version 2020.0.5). We aligned a total of 222 SARS-CoV-2 genome sequences comprising at least 5 representative sequences from phylogenetic lineages defined by Rambaut et al., ranging from January 5 to March 31, 2020 from 25 different countries. We performed phylogenetic reconstruction with BEAST (version 1.10.4, strict molecular clock, HKY + Γ nucleotide substitution, exponential growth for coalescent model). The ASU sequences were phylogenetically distinct indicating that they were independent transmissions (Figure 2A).

Similar to SARS-CoV, the SARS-CoV-2 genome encodes multiple open reading frames in the 3’ region. We found that the SARS-CoV-2 AZ-ASU2923 genome has an 81 base-pair deletion in the ORF7a gene resulting in a 27 amino-acid in-frame deletion (Figure 2B). The SARS-CoV ORF7a ortholog is a viral antagonist of host restriction factor BST-2/Tetherin and induces apoptosis. Based on the SARS-CoV ORF7a structure, the 27-aa deletion in SARSCoV-2 ORF7a maps to the putative signal peptide (partial) and first two beta strands. To validate the deletion, we performed RT-PCR using primers spanning the region and verified by Sanger sequencing the amplicons (Figure 2C and Supplementary Figure 1).

Collectively, although global NGS efforts indicate that SARS-CoV-2 genomes are relatively stable, dynamic mutations can be selected in symptomatic individuals.

References 18

  1. 1.
    Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 · 2020
    No notice
  2. 2.

    CDC. 2020 2019-Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Panel Primers and Probes. https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-primer-probes.pdf Accessed 3/4/2020.

    Not in our library

  3. 3.
    Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR · 2020
    Expression of concern
  4. 4.

    Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. 2020 The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med

    Not in our library10.7326/m20-0504

  5. 5.

    Polgreen PM, Bohnett LC, Yang M, Pentella MA, Cavanaugh JE. 2010 A spatial analysis of the spread of mumps: the importance of college students and their spring-break-associated travel. Epidemiol Infect 138:434–41.

    Not in our library10.1017/s0950268809990719

  6. 6.

    Rambaut A, Holmes EC, Pybus OG. 2020 A dynamic nomenclature for SARS-CoV-2 to assist genomic epidemiology. http://virological.org/t/a-dynamic-nomenclature-for-sars-cov-2-to-assist-genomic-epidemiology/458.

    Not in our library10.1038/s41564-020-0770-5

  7. 7.
    Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10 · 2018
    No notice
  8. 8.

    Hasegawa M, Kishino H, Yano T-a. 1985 Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. Journal of Molecular Evolution 22:160–174.

    Not in our library10.1007/bf02101694

  9. 9.

    Yang Z. 1994 Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: Approximate methods. Journal of Molecular Evolution 39:306–314.

    Not in our library10.1007/bf00160154

  10. 10.

    Pybus OG, Rambaut A. 2002 GENIE: estimating demographic history from molecular phylogenies. Bioinformatics 18:1404–1405.

    Not in our library10.1093/bioinformatics/18.10.1404

  11. 11.

    Taylor JK, Coleman CM, Postel S, Sisk JM, Bernbaum JG, Venkataraman T, Sundberg EJ, Frieman MB. 2015 Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference. J Virol 89:11820–33.

    Not in our library10.1128/jvi.02274-15

  12. 12.

    Yuan X, Wu J, Shan Y, Yao Z, Dong B, Chen B, Zhao Z, Wang S, Chen J, Cong Y. 2006 SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology 346:74–85.

    Not in our library10.1016/j.virol.2005.10.015

  13. 13.

    Tan YJ, Fielding BC, Goh PY, Shen S, Tan TH, Lim SG, Hong W. 2004 Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol 78:14043–7.

    Not in our library10.1128/jvi.78.24.14043-14047.2004

  14. 14.

    Schaecher SR, Touchette E, Schriewer J, Buller RM, Pekosz A. 2007 Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol 81:11054–68.

    Not in our library10.1128/jvi.01266-07

  15. 15.

    Nelson CA, Pekosz A, Lee CA, Diamond MS, Fremont DH. 2005 Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure 13:75–85.

    Not in our library10.1016/j.str.2004.10.010

  16. 16.
    Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7 · 2018
    No notice
  17. 17.

    Rambaut A. 2018 FigTree v1.4.4, https://github.com/rambaut/figtree.

    Not in our library

  18. 18.

    O’Toole A, McCrone J. 2020 pangolin, https://github.com/hCoV-2019/pangolin.

    Not in our library

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.